Gran Asia Life Sciences Llp - Company Profile

It is a pharma limited liability partnership based in Mumbai, Maharashtra, India, established in 2019.
2019 Mumbai, Maharashtra, India Active
Last Updated:
About Gran Asia Life Sciences Llp

Gran Asia Life Sciences Llp, a active limited liability partnership, was established on 13 June 2019 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds LLPIN: AAP-6168. Registered under ROC Roc Mumbai. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Rajesh Gangaram Lonkar (Designated Partner), Pradip Baban Taware (Designated Partner). Past directors included Yogesh Murlidhar Gaikwad, Sandip Sudam Mehetre, Shivaji Eknath Narawade. Its latest date of accounts and solvency statement 31 March 2025. It is based at Shop No. 10, Devdoot Chs, Bldg No. 106, New Mahada Colony, Nr Pmgp Colony, Gm Link Road, Ma, Nkhurd (W), Mumbai, Maharashtra, 400088.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAP-6168

  • Incorporation Date

    13 June 2019

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 6 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Gran Asia Life Sciences Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Gran Asia Life Sciences Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Gran Asia Life Sciences Llp?
Current Designated Partners
Name Designation Appointment Date Status
Rajesh Gangaram Lonkar Designated Partner 13 Jun 2019 Current
Pradip Baban Taware Designated Partner 13 Jun 2019 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Partner - Past
Pramod Abcsdd Partner - Past
Pramod Abcsdd Partner - Past
Pramod Abcsdd Partner - Past
Pramod Abcsdd Partner - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Gran Asia Life Sciences Llp.

Enhance accessibility to Gran Asia Life Sciences Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Gran Asia Life Sciences Llp revenue growth over time
Gran Asia Life Sciences Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Gran Asia Life Sciences Llp?

Unlock access to Gran Asia Life Sciences Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Gran Asia Life Sciences Llp?

Unlock and access historical data on people associated with Gran Asia Life Sciences Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Gran Asia Life Sciences Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gran Asia Life Sciences Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Gran Asia Life Sciences Llp
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Gran Asia Life Sciences Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was documented.

  • Statement of Assets & Liabilities

    The activity Gran Asia Life Sciences Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.

  • Director Appointment

    The activity Rajesh Gangaram Lonkar was appointed as a Designated Partner was appointed as a Designated Partner on 13 Jun 2019 & has been associated with this company since 6 years 8 months . was completed.

  • Director Appointment

    Pradip Baban Taware was appointed as a Designated Partner was appointed as a Designated Partner on 13 Jun 2019 & has been associated with this company since 6 years 8 months . was recorded as a recent event.

  • LLP Incorporation

    Gran Asia Life Sciences Llp was registered on 13 Jun 2019 with Roc Mumbai & aged 6 years 8 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Gran Asia Life Sciences Llp?

The LLPIN of Gran Asia Life Sciences Llp is AAP-6168.

Where is Gran Asia Life Sciences Llp headquartered?

Gran Asia Life Sciences Llp is headquartered at Shop No. 10, Devdoot Chs, Bldg No. 106, New Mahada Colony, Nr Pmgp Colony, Gm Link Road, Ma, Nkhurd (W), Mumbai, Maharashtra, 400088.

When was Gran Asia Life Sciences Llp incorporated?

Gran Asia Life Sciences Llp was incorporated on 13 June 2019.

Who are the current directors of Gran Asia Life Sciences Llp?

The current directors of Gran Asia Life Sciences Llp are

What is the primary industry of Gran Asia Life Sciences Llp?

The primary industry of Gran Asia Life Sciences Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available